T. Rowe Price Associates’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,084,247	Closed	-$15.4M	–	2995
2023 Q4	$15.4M	Buy	1,084,247 +262,683	+32%	+$3.74M	﹤0.01%	1005
2023 Q3	$9.45M	Sell	821,564 -107,753	-12%	-$1.24M	﹤0.01%	1077
2023 Q2	$15.3M	Buy	929,317 +718,690	+341%	+$11.8M	﹤0.01%	1002
2023 Q1	$1.88M	Buy	+210,627	New	+$1.88M	﹤0.01%	1478